Latest Technology Platforms News

Praemium Limited is undertaking a major restructure of its technology division following its acquisition of Technotia Laboratories, aiming to streamline operations and reduce costs while enhancing technological capabilities.

The week was split between big earnings reactions and small-cap rocks-and-rigs rallies. Pro Medicus sank despite record numbers, while a handful of explorers jumped on fresh discoveries and policy wins.

Takeover chatter lit up Pepper Money, while Identitii ran hard after a regulator stepped in. At the other end, AMP slid despite higher profit, as investors weighed leadership change and legal costs.

Ovanti Limited has completed a $1.08 million capital raise through a large share placement aimed at funding its growing U.S. buy now, pay later business and global operations.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.

Assetora Limited is set to be delisted from the ASX after a two-year suspension, with the company exploring a fresh listing on the National Stock Exchange of Australia to better suit its evolving business model.

Viva Leisure has reported a striking 168% jump in net profit after tax for HY2026, driven by strong revenue growth and a booming technology segment. The company’s strategic shift towards technology and network optimisation is paying off, with cash flow and membership numbers also on the rise.

Origin Energy reported robust half-year results for December 2025, driven by strong Energy Markets performance and significant customer growth, while updating FY26 guidance with higher earnings expectations.

humm Group reports a $13.9 million statutory profit for 1H26, driven by commercial lending growth and strong consumer segment performance despite rising credit losses and regulatory costs.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

Credit stocks swung hard, with Credit Corp sliding despite steady profits and a busy acquisition agenda. Payments and capital management stories did the heavy lifting elsewhere, from Klevo’s Mastercard milestones to Regal’s buy-back.

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.